News
VALN
--
0.00%
--
22 Stocks Moving in Friday's Pre-Market Session
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month.
Benzinga · 11h ago
What you need to know about the coronavirus right now
Here's what you need to know about the coronavirus right now:
Reuters · 1d ago
24 Stocks Moving in Thursday's Pre-Market Session
Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business combination with Jasper Therapeutics.
Benzinga · 1d ago
Valneva Continues To Expand COVID-19 Vaccine Candidate Trials
Benzinga · 1d ago
Valneva expands trials on COVID-19 vaccine candidate
French vaccine maker Valneva is expanding trials of a COVID-19 vaccine candidate called VLA2001, and remains in talks with the European Commission over a potential contract, the company said on Thursday.
Reuters · 1d ago
Valneva Expands Covid Vaccine Trials, Continues Talks With EU
Bloomberg · 1d ago
Valneva Continues Expansion of Clinical Trials of its Inactivated COVID-19 Vaccine Candidate VLA2001
Commences recruitment of Adolescents into Phase 3 trial “Cov-Compare”Enrolls participants in the Phase 1/2 Booster Trial Saint-Herblain (France), September 23, 2021 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA) a specialty vaccine company, today announ...
GlobeNewswire · 1d ago
Valneva Starts Recruitment of Adolescents to Late-Stage COVID-19 Trial; Starts Giving Booster Shots in Separate Study
MT Newswires · 1d ago
20 Stocks Moving in Wednesday's Pre-Market Session
Gainers
Benzinga · 2d ago
32 Stocks Moving In Tuesday's Mid-Day Session
Gainers Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 177.4% to $39.83. Helbiz Media, the media arm of Helbiz announced a deal with Amazon Italy, a unit of Amazon.com. ReWalk Robotics Ltd. (NASDAQ: RWLK) jumped 48.3% to $1.9284 after declining around 4% on Mon...
Benzinga · 3d ago
UK would not have approved Valneva COVID vaccine, health secretary says
Britain cancelled its contract for about 100 million doses of a COVID-19 vaccine being developed by France's Valneva in part because it was clear it would not be approved for use in the country, UK Health Secretary Sajid Javid said on Tuesday.
Reuters · 09/14 18:27
Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Valneva SE (VALN) Investigation
NEW YORK, NY / ACCESSWIRE / September 14, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE ("Valneva" or the "Company") (NASDAQ:VALN). Investors who purchased Valneva sharesare encouraged to ...
ACCESSWIRE · 09/14 15:00
UPDATE 1-UK would not have approved Valneva COVID vaccine, health secretary says
reuters.com · 09/14 12:55
Biden to announce new pandemic steps ahead of U.N. meeting Tuesday, as global COVID-19 case tally nears 225 million
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 climbed closer to 225 million on Monday with the U.S. leading by cases and deaths and the U.S. surgeon general said President Joe Biden's vaccine mandates are legal and effective...
Marketwatch.com · 09/14 11:28
72 Biggest Movers From Yesterday
Gainers
Benzinga · 09/14 08:50
Valneva Completes Recruitment of Elderly Participants in Phase 3 Trial of its Inactivated COVID-19 Vaccine
Saint-Herblain (France), September 14, 2021 – Valneva SE, a specialty vaccine company, today announced that it has completed recruitment of the initial cohort of elderly participants in Valneva’s Phase 3 trial, VLA2001-304, of its inactivated COVID-19 vacc...
GlobeNewswire · 09/14 05:00
Valneva Completes Enrollment of Elderly Patients in Phase 3 Trial of COVID-19 Vaccine Candidate
MT Newswires · 09/14 04:55
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53.
Benzinga · 09/13 18:40
U.K. Canceling $1.7 Billion Vaccine Contract With Valneva Is a Bizarre Rug-Pull
Bloomberg · 09/13 16:24
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75.
Benzinga · 09/13 16:17
Webull provides a variety of real-time VALN stock news. You can receive the latest news about Valneva SE through multiple platforms. This information may help you make smarter investment decisions.
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.